These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 38106972)

  • 21. Systems biology strategy and experimental validation to uncover the pharmacological mechanism of Xihuang Pill in treating non-small cell lung cancer.
    Zhuang Z; Huang D; Sheng ZR; Ye ZJ; Jiang H; Yuan Y; Qin B; Zhao Y; Pan HF; Tang Y
    Phytomedicine; 2023 Jan; 108():154491. PubMed ID: 36368285
    [TBL] [Abstract][Full Text] [Related]  

  • 22. M6A regulator expression patterns predict the immune microenvironment and prognosis of non-small cell lung cancer.
    Liu X; Ma C; Liu H; Sun Z; Luo J
    J Cancer Res Clin Oncol; 2022 Oct; 148(10):2803-2814. PubMed ID: 35596010
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Prognostic biomarkers correlated with immune infiltration in non-small cell lung cancer.
    Xu F; Cui WQ; Liu C; Feng F; Liu R; Zhang J; Sun CG
    FEBS Open Bio; 2023 Jan; 13(1):72-88. PubMed ID: 36282125
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prognostic and immunomodulatory roles of schizophrenia-associated genes HTR2A, COMT, and PRODH in pan-cancer analysis and glioma survival prediction model.
    Shen J; Wang Q; Lu F; Xu H; Wang P; Feng Y
    Front Immunol; 2023; 14():1201252. PubMed ID: 37564635
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioinformatics analysis of the circRNA-miRNA-mRNA network for non-small cell lung cancer.
    Cai X; Lin L; Zhang Q; Wu W; Su A
    J Int Med Res; 2020 Jun; 48(6):300060520929167. PubMed ID: 32527185
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comprehensive analysis of scRNA-Seq and bulk RNA-Seq reveals dynamic changes in the tumor immune microenvironment of bladder cancer and establishes a prognostic model.
    Tan Z; Chen X; Zuo J; Fu S; Wang H; Wang J
    J Transl Med; 2023 Mar; 21(1):223. PubMed ID: 36973787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Validation and analysis of expression, prognosis and immune infiltration of WNT gene family in non-small cell lung cancer.
    Wang J; Yang Q; Tang M; Liu W
    Front Oncol; 2022; 12():911316. PubMed ID: 35957916
    [TBL] [Abstract][Full Text] [Related]  

  • 28.
    Ji W; Niu X; Yu Y; Li Z; Gu L; Lu S
    Front Immunol; 2022; 13():955800. PubMed ID: 36405701
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Integrating Single-cell RNA-seq to construct a Neutrophil prognostic model for predicting immune responses in non-small cell lung cancer.
    Pang J; Yu Q; Chen Y; Yuan H; Sheng M; Tang W
    J Transl Med; 2022 Nov; 20(1):531. PubMed ID: 36401283
    [TBL] [Abstract][Full Text] [Related]  

  • 30. FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC.
    Hu DM; Zhang WD; Shi ZE; Zhang MY; Li R; Wang QX; Ji XL; Qu YQ
    Front Genet; 2022; 13():937069. PubMed ID: 36160018
    [No Abstract]   [Full Text] [Related]  

  • 31. Pan-cancer analysis of the prognostic and immunological role of BRCA1-associated protein 1 gene (BAP1): Friend or foe?
    Wang T; Zhu T; Zhang Y; Bai J; Xue Y; Xu G; Lu L; Peng Q
    Gene; 2022 Oct; 840():146765. PubMed ID: 35905855
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of the Significance of Immune Cell Infiltration and Prognosis of Non-Small-Cell Lung Cancer by Bioinformatics.
    Sun H; Sui B; Li Y; Yan J; Cao M; Zhang L; Liu S
    J Healthc Eng; 2021; 2021():3284186. PubMed ID: 34603645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pan-Cancer Analysis Shows That ALKBH5 Is a Potential Prognostic and Immunotherapeutic Biomarker for Multiple Cancer Types Including Gliomas.
    Wei C; Wang B; Peng D; Zhang X; Li Z; Luo L; He Y; Liang H; Du X; Li S; Zhang S; Zhang Z; Han L; Zhang J
    Front Immunol; 2022; 13():849592. PubMed ID: 35444654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ANXA2 is a potential biomarker for cancer prognosis and immune infiltration: A systematic pan-cancer analysis.
    Ning Y; Li Y; Wang H
    Front Genet; 2023; 14():1108167. PubMed ID: 36713082
    [No Abstract]   [Full Text] [Related]  

  • 35. Development and validation a prognostic model based on natural killer T cells marker genes for predicting prognosis and characterizing immune status in glioblastoma through integrated analysis of single-cell and bulk RNA sequencing.
    Hu J; Xu L; Fu W; Sun Y; Wang N; Zhang J; Yang C; Zhang X; Zhou Y; Wang R; Zhang H; Mou R; Du X; Li X; Hu S; Xie R
    Funct Integr Genomics; 2023 Aug; 23(3):286. PubMed ID: 37650991
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Systematic Analysis of the Prognostic Significance and Roles of the Integrin Alpha Family in Non-Small Cell Lung Cancers.
    Huang Y; Guo DM; Bu S; Xu W; Cai QC; Xu J; Jiang YQ; Teng F
    Adv Ther; 2023 May; 40(5):2186-2204. PubMed ID: 36892810
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A novel tumor mutational burden-based risk model predicts prognosis and correlates with immune infiltration in ovarian cancer.
    Wang H; Liu J; Yang J; Wang Z; Zhang Z; Peng J; Wang Y; Hong L
    Front Immunol; 2022; 13():943389. PubMed ID: 36003381
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of SHCBP1 as a potential biomarker involving diagnosis, prognosis, and tumor immune microenvironment across¬†multiple¬†cancers.
    Wang N; Zhu L; Wang L; Shen Z; Huang X
    Comput Struct Biotechnol J; 2022; 20():3106-3119. PubMed ID: 35782736
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High expression of MYEOV reflects poor prognosis in non-small cell lung cancer.
    Zhang R; Ma A
    Gene; 2021 Feb; 770():145337. PubMed ID: 33278551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The prognostic value of tumor mutation burden (TMB) and its relationship with immune infiltration in breast cancer patients.
    Cui S; Feng J; Tang X; Lou S; Guo W; Xiao X; Li S; Chen X; Huan Y; Zhou Y; Xiao L
    Eur J Med Res; 2023 Feb; 28(1):90. PubMed ID: 36805828
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.